Moreover, by analyzing The Cancer Genome Atlas (TCGA) program database, we found that besides HCC, galectin-14 aberrantly expressed in a series of tumor types, especially induced by gene copy number amplification (Fig. 2C), and aberrant alterations of the galectin-14 gene in the genome showed a significant association with a poor survival in patients with pan-cancer (Fig. 2D). The gene discussed is LGALS14; the disease is hepatocellular carcinoma.